Remote Monitoring During Clinical Trials - COVID-19 Update
Remote monitoring in clinical trials has never been so popular. This article explains a risk-based approach to remote monitoring and remote SDV
Remote monitoring in clinical trials has never been so popular. This article explains a risk-based approach to remote monitoring and remote SDV
The recent ICHGCP E6 (R2) addendum have resulted in the need for statistical programmers and biostatisticians to play an important role in risk-based monitoring
The future of Risk Based & Remote Monitoring, how globalisation has caused the FDA to advise risk mitigation and the fear of flouting regulatory compliance
This infographic presents survey data that indicates the increase in the use of risk-based monitoring and how data from trials using RBM solutions has risen
This Quanticate blog post examines the rise of Risk Based Monitoring in clinical trials and growing trends from industry data in the adoption of RBM
A video of Kelci Miclaus from SAS JMP speaking at Clinical Data Live 2013, discussing Efficient Data Reviews and Quality in Clinical Trials.